SCHEMBL30837931

SCHEMBL30837931

COc1cc(Cn2c(=O)c3cc(OC(CF)CF)ccc3n(C3CCN(C=O)CC3)c2=O)ccc1OC1CCCC1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 10/20 0.87
▸ PDE7B Q9NP56 5/20 0.87
▸ PDE8A O60658 3/20 0.87
▸ PDE4B Q07343 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ RECQL P46063 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PRKDC P78527 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ C5AR1 P21730 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ CRHBP P24387 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100095 1.00 PDE7A (0.87) PDE7APDE7BPDE8APDE4BMEN1
SCHEMBL100102 0.97 PDE7A (0.87) PDE7APDE7BPDE8APDE4BMEN1
SCHEMBL100140 0.96 PDE7A (0.79) PDE7APDE7BPDE8APDE4BMEN1
SCHEMBL100998 0.95 PDE7A (0.78) PDE7APDE7BPDE8APDE4BMEN1
SCHEMBL99927 0.94 PDE7A (0.77) PDE7APDE7BPDE8APDE4BMEN1
SCHEMBL30837881 0.93 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100704 0.93 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL101004 0.93 PDE7A (0.75) PDE7APDE7BPDE8APDE4BMEN1
SCHEMBL30837934 0.93 PDE7A (0.75) PDE7APDE7BPDE8APDE4BMEN1
SCHEMBL99932 0.92 PDE7A (0.91) PDE7APDE7BPDE8AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 — — EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 — — WO disclosed
Send feedback